Evidence map›Paper›PMID 35179712›Full record

ReviewCurrent psychiatry reports2022

Neuromodulation and Eating Disorders.

L Gallop, M Flynn, I C Campbell, U Schmidt

Open access · hybridAbstract readReview
In one paragraph

Review in Current psychiatry reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. rTMS Therapy for Eating Disorders: Scoping Review on Efficacy, Safety, Stimulation Parameters and Study Subjects.European eating disorders review : the journal of the Eating Disorders Association · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. ExoTMS transcranial magnetic stimulation for the reduction of binge eating symptoms.PCN reports : psychiatry and clinical neurosciences · 2025
    Article
  9. Article
  10. Article
  11. The current clinical approach to feeding and eating disorders aimed to increase personalization of management.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

L GallopSection of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, King's College London, Psychology & Neuroscience, London, UK.
M FlynnSection of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, King's College London, Psychology & Neuroscience, London, UK.
I C CampbellSection of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, King's College London, Psychology & Neuroscience, London, UK.
U SchmidtSection of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, King's College London, Psychology & Neuroscience, London, UK. ulrike.schmidt@kcl.ac.uk.
King's College London · GBSouth London and Maudsley NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewWe review recent evidence on the use of neuromodulation for treating eating disorders (EDs), including anorexia nervosa, bulimia nervosa and binge eating disorder. We evaluate studies on (a) modern non-invasive methods of brain stimulation, such as transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), (b) electroconvulsive therapy (ECT) and (c) more invasive techniques, including deep brain stimulation (DBS). RECENT

findingsMost reports on the clinical applications of neuromodulation in EDs are limited to case studies, case series and small clinical trials. The majority have focused on severe, enduring and hard-to-treat cases of AN. In this population, data suggest that both rTMS and DBS have therapeutic potential and are safe and acceptable. High-quality clinical trials in different ED populations are needed which investigate different stimulation methods, sites and parameters, the use of neuromodulation as stand-alone and/or adjunctive treatment, as well as the mechanisms of action.

Indexed as

Anorexia NervosaBulimia NervosaFeeding and Eating DisordersTranscranial Direct Current StimulationHumansTranscranial Magnetic StimulationAnorexia nervosaBrain stimulationEating disordersNeuromodulationTranscranial direct current stimulationTranscranial magnetic stimulation

Identifiers

PMID35179712
PMCPMC8898249
OpenAlexW4213264121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.